Market Cap : 2.24 B | Enterprise Value : 23.47 B | PE Ratio : 53.15 | PB Ratio : |
---|
NYSE:BHC has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NYSE:BHC has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Days Inventory is also known as Days Sales of Inventory (DSI). Bausch Health's Average Total Inventories for the three months ended in Jun. 2022 was $1,059 Mil. Bausch Health's Cost of Goods Sold for the three months ended in Jun. 2022 was $577 Mil. Hence, Bausch Health's Days Inventory for the three months ended in Jun. 2022 was 167.48.
The historical rank and industry rank for Bausch Health's Days Inventory or its related term are showing as below:
During the past 13 years, Bausch Health's highest Days Inventory was 181.13. The lowest was 131.93. And the median was 156.81.
BHC's Days Inventory is ranked worse thanBausch Health's Days Inventory increased from Jun. 2021 (161.18) to Jun. 2022 (167.48). It might indicate that Bausch Health's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year. Bausch Health's Inventory Turnover for the three months ended in Jun. 2022 was 0.54.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Bausch Health's Inventory-to-Revenue for the three months ended in Jun. 2022 was 0.54.
The historical data trend for Bausch Health's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Bausch Health's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Bausch Health's Days Inventory distribution charts can be found below:
* The bar in red indicates where Bausch Health's Days Inventory falls into.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Bausch Health's Days Inventory for the fiscal year that ended in Dec. 2021 is calculated as
Days Inventory (A: Dec. 2021 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (A: Dec. 2020 ) | + | Total Inventories (A: Dec. 2021 )) | / | count ) | / | Cost of Goods Sold (A: Dec. 2021 ) | * | Days in Period |
= | ( (1094 | + | 993) | / | 2 ) | / | 2394 | * | 365 |
= | 1043.5 | / | 2394 | * | 365 | ||||
= | 159.10 |
Bausch Health's Days Inventory for the quarter that ended in Jun. 2022 is calculated as:
Days Inventory (Q: Jun. 2022 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (Q: Mar. 2022 ) | + | Total Inventories (Q: Jun. 2022 )) | / | count ) | / | Cost of Goods Sold (Q: Jun. 2022 ) | * | Days in Period |
= | ( (1045 | + | 1073) | / | 2 ) | / | 577 | * | 365 / 4 |
= | 1059 | / | 577 | * | 365 / 4 | ||||
= | 167.48 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Bausch Health's Inventory Turnover for the three months ended in Jun. 2022 is calculated as
Inventory Turnover | = | Cost of Goods Sold | / | Average Total Inventories |
= | 577 | / | 1059 | |
= | 0.54 |
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Bausch Health's Inventory to Revenue for the three months ended in Jun. 2022 is calculated as
Inventory-to-Revenue | = | Average Total Inventories | / | Revenue |
= | 1059 | / | 1967 | |
= | 0.54 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Thank you for viewing the detailed overview of Bausch Health's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Carson Seana | officer: EVP, General Counsel | 400 SOMERSET CORPORATE BLVD BRIDGEWATER NJ 08807 |
Vadaketh Tom George | officer: EVP, Chief Financial Officer | 1727 JOCKEYS WAY YARDLEY PA 19067 |
Mulligan Richard | director | C/O ICAHN CAPITAL LP 767 FIFTH AVENUE, SUITE 4700 NEW YORK NY 10153 |
Munsch Frederick | officer: SVP, Controller and CAO | 400 SOMERSET CORPORATE BLVD. BRIDGEWATER NJ 08807 |
Gordon Joseph F | officer: Pres&Co-Head Bausch&Lomb/Int'l | 400 SOMERSET CORPORATE BLVD. BRIDGEWATER NJ 08807 |
Ackermann Christina | officer: EVP AND GENERAL COUNSEL | C/O BLCO 400 SOMERSET CORPORATE BLVD. BRIDGEWATER NJ 08807 |
Spurr Robert | director, officer: U.S. President-Pharma Business | C/O BAUSCH HEALTH COMPANIES INC. 400 SOMERSET CORPORATE BLVD. BRIDGEWATER NJ 08807 |
Eldessouky Sam | officer: EVP & Chief Financial Officer | C/O BAUSCH HEALTH COMPANIES INC. 400 SOMERSET CORPORATE BLVD. BRIDGEWATER NJ 08807 |
Miller Steven D | director | 16690 COLLINS AVENUE PH SUNNY ISLE BEACH FL 33160 |
Icahn Brett | director | C/O ICAHN ENTERPRISES L.P. 16690 COLLINS AVE., PH SUNNY ISLES FL 33160 |
Paulson John | director | 1133 AVENUE OF THE AMERICAS 33RD FLOOR NEW YORK NY 10036 |
Valueact Holdings Ii, L.p. | director, other: See Remarks | ONE LETTERMAN DRIVE BUILDING D, FOURTH FLOOR SAN FRANCISCO CA 94129 |
Von Eschenbach Andrew C. | director | BAUSCH HEALTH COMPANIES INC. 400 SOMERSET CORPORATE BLVD. BRIDGEWATER NJ 08807 |
Mckenna Mark C. | officer: President, Salix | 400 SOMERSET CORPORATE BOULEVARD BRIDGEWATER NJ 08807 |
Humphries William D. | officer: EVP, COMPANY GROUP CHAIRMAN | C/O STRATA SKIN SCIENCES, INC. 5 WALNUT GROVE DRIVE SUITE 140 HORSHAM PA 19044 |
From GuruFocus
By PRNewswire 03-29-2022
Other Sources
By Zacks 2022-02-08
By Zacks 2022-03-30
By Zacks 2022-01-21
By Zacks 2022-02-22
By Zacks 2022-01-14
By Seekingalpha 2022-01-31
By Zacks 2022-01-31
By Zacks 2022-04-05
By Zacks 2022-03-25
By Zacks 2022-01-24
By Zacks 2022-03-22
By Zacks 2022-01-26
By tipranks.com 2022-02-23